Penfield Search Partners is a niche permanent and contract recruiting firm with a strong focus on the quantitative sciences within the pharmaceutical and biotech industry. Our group of highly experienced search professoinals is dedicated to finding you the right resource at the right time. To learn more, visit http://www.penfieldsearch.com/

Biological Dynamics, Inc. is a company committed to improving health outcomes by detecting diseases at the earliest stages. The Company’s proprietary ExoVerita™ platform simplifies isolation of extracellular vesicles, enabling multiomic applications. Its ExoVita™ Pancreas Test operates in a College of American Pathologists (CAP) accredited, CLIA-certified clinical laboratory in San Diego.

Cytel is the largest provider of statistical software and advanced analytics for clinical trial design and execution. For over thirty years, Cytel’s scientific rigor and operational excellence have enabled biotech and pharmaceutical companies to navigate uncertainty, prove value and make confident, evidence- based decisions. Our experts deliver industry-leading software, data-driven analytics, real-world evidence and strategic consulting. Headquartered in Waltham, Massachusetts, Cytel has more than 1,400 employees across North America, Europe and Asia. For more information about Cytel, please visit us at www.cytel.com. You also can follow us on LinkedIn and Twitter and like us on Facebook.

PROMETRIKA, LLC a global clinical research organization (CRO) expertly supporting the biotechnology industry since 2003. Our team has successfully delivered hundreds of clinical studies across all phases and major therapeutic areas. We offer full services in clinical operations, data management, biostatistics and programming, medical writing, pharmacovigilance, and regulatory submissions. To learn more, please visit www.prometrika.com

For biotech and pharma companies developing precision medicines, Sano Genetics is the precision patient platform that unifies recruitment, genetic testing, and long-term participant engagement into a modular, compliant, and data-rich solution. Sano’s end-to-end approach reduces risk, cost, and drop-out while building valuable, recontactable patient cohorts for now and the future. For more information please visit  www.sanogenetics.com

AARDEX Group stands tall as the world’s foremost authority on digital solutions for measuring and managing medication adherence. We are dedicated to creating cutting-edge digital solutions that boost adherence during clinical trials. Our MEMS® Adherence Software lies at the heart of a complete ecosystem that combines a range of medication adherence packages and devices, allowing us to measure medication adherence across all routes of drug administration. Our vision is to continually innovate, producing data-driven medication adherence solutions that enhance digital therapeutics and empower patients. We strive to revolutionize the way participants manage their health and take their medication, breaking down barriers and leading the way forward. At AARDEX Group, we are passionate about empowering patients, and our dedication to developing and implementing innovative technologies is what sets us apart. To learn more, please visit www.aardexgroup.com

Arriello is a leading consultancy and solutions provider of risk management and compliance services to the pharmaceutical industry. We’ve been making the development-to-market process faster, better, and smarter since 2008. Our global services span the product life cycle from Clinical to post-submission Regulatory Affairs and Pharmacovigilance, Quality Assurance and Auditing, and innovative automation solutions. We aim to be your partner of choice for your journey to market, and throughout the life cycle of your products. Our ability to provide a tailored, focused small-company service, allied to the ability to help drive large projects with scale and footprint is unmatched in the industry. Nobody else is better positioned than Arriello to provide the personalized and attentive service needed for all your requirements across the product life cycle. To learn more, please visit www.arriello.com

qPharmetra provides quantitative pharmacology and pharmacometrics consulting to help sponsors make better clinical development decisions, ultimately leading to better medicines for patients. Pharmacokinetics and exposure-response relationships are central in FDA and EMA’s assessment of NDAs and BLAs. First-in-man (FiM) trials, dose selection, minimally effective dose, etc., are all informed by approaches quantifying drug exposure (pharmacokinetics) and drug effect (pharmacodynamics), ultimately embedded in exposure-response frameworks. These exposure-response frameworks can be created for efficacy as well as safety signals and are as such a central quantitative basis for decision making throughout clinical development. For example, what’s the dose escalation scheme for your FiM trial? Or what is the Recommended Phase 2 Dose (R2PD)? Regulators require sponsors to start with building these frameworks as early as possible, already in the preclinical setting. We are the exposure-response experts! Let data science speed up and rationalize your clinical development decisions by qPharmetra’s clinical pharmacology and pharmacometrics consultants. To learn more, please visit www.qpharmetra.com

Worldwide Clinical Trials (Worldwide) is a leading global contract research organization (CRO) that works in partnership with biotechnology and pharmaceutical companies to create customized solutions that advance new medications, from discovery to reality. Our full-service clinical development capabilities include bioanalytical laboratory services and Phase I-IV clinical trials, as well as post-approval and real-world evidence studies – all powered by our talented and accessible team of clinicians, scientists, and researchers who bring their first-hand expertise to each clinical program.

At Worldwide, we understand that each customer and project are unique, so we take a collaborative and personalized approach to identify and meet specific needs and goals. Anchored in our company’s scientific heritage, we are therapeutically focused on cardiovascular, metabolic, neuroscience, oncology, and rare diseases. We apply this deep therapeutic knowledge to develop flexible plans and quickly solve problems in the rapidly evolving clinical development landscape.

Our team of 3,000+ professionals spans 60+ countries, and believes that through collaboration, and a culture that embraces diversity, equity, inclusion, and belonging (DEI&B), everyone plays an important role in making a world of difference for patients and their caregivers. We are united in cause with our customers to improve the lives of patients through new, innovative therapies.

For more information on Worldwide, visit www.Worldwide.com or connect with us on LinkedIn.

4C Pharma provides end-to-end Pharmacovigilance and Regulatory services in Medical Information Call Center, Literature Search, Case Processing, Periodic Reports, Signal and Risk Management with in-house Argus. Well versed in global regulations and systems, we provide 100% customizable safety services. We can get a quote for you in 48 hours. Info@4Cpharma.com

KeborMed delivers the industry’s most advanced, regulatory compliant connectivity platform for MedTech and Pharma applications. Our plug-n-play solution transforms data management, bypassing traditional custom development hurdles. This empowers businesses to expedite high-quality drug discovery and delivery, significantly enhancing patient care and providing a competitive edge in the rapidly evolving healthcare landscape. To learn more, please visit https://kebormed.com/

Kaléo is dedicated to creating innovative healthcare solutions that help protect and empower patients. Our auto-injection technologies are protected by an extensive intellectual property portfolio of patents and meet the FDA draft guidance standard for 99.999% device reliability. Kaléo is privately-held and headquartered in Richmond, VA. Visit www.kaleo.com